CuraGen Repurchases $50.9 Million of 2011 Convertible Debt for $43.2 - MSN MoneyCentral
May 14th, 2008 by admin
Medarex shares rise following analyst upgrade - Forbes
Shares of biotechnology company Medarex Inc. rose Tuesday after a Needham & Co. analyst raised his rating on shares to “Buy” from “Hold,” based on the company’s pipeline and developments expected throughout the year. Shares of Medarex rose 97 cents
Source: www.forbes.com
Run raises funds for skin cancer research - Wisconsin Dells Events
Organizers are gearing up for the second year of the Block The Sun Run at Spring Brook Resort. Last year 475 people ran a 5-kilometer race and 3-kilometer walk. So far this year 100 people are signed up to participate whereas last year at this time
Source: www.wiscnews.com